The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Dagher Ibrahim B. | Director | Grant(A) | 225K | $0.70 | $158K |
| Feb 26, 2026 | Naor Nir | Director | Grant(A) | 180K | $0.70 | $126K |
| Feb 26, 2026 | Lindborg Stacy | Director | Grant(A) | 150K | $0.70 | $105K |
| Feb 26, 2026 | Hartounian Hartoun | Director | Grant(A) | 225K | $0.70 | $158K |
| Feb 26, 2026 | Polverino Anthony J. | Director | Grant(A) | 150K | $0.70 | $105K |
| Feb 26, 2026 | Bairu Menghisteab | Director | Grant(A) | 150K | $0.70 | $105K |
| Feb 26, 2026 | Arbel Irit | Director | Grant(A) | 120K | — | $0 |
| Feb 26, 2026 | Frenkel Jacob A | Director | Grant(A) | 200K | — | $0 |
| Feb 26, 2026 | Patlis Alla | See Remarks | Grant(A) | 100K | — | $0 |
| Feb 26, 2026 | Yablonka Uri | EVP & Chief Business Officer, Director | Grant(A) | 150K | — | $0 |
| Feb 26, 2026 | Lebovits Chaim | President & CEO | Grant(A) | 1.8M | — | $0 |
| Jan 1, 2025 | Arbel Irit | Director | Grant(A) | 31K | — | $0 |
| Jan 1, 2025 | Bairu Menghisteab | Director | Grant(A) | 24K | — | $0 |
| Jan 1, 2025 | Hartounian Hartoun | EVP, Chief Operating Officer | Grant(A) | 50K | — | $0 |
| Jan 1, 2025 | Lindborg Stacy | Director | Grant(A) | 20K | — | $0 |
| Jan 1, 2025 | Naor Nir | Director | Grant(A) | 31K | — | $0 |
| Jan 1, 2025 | Patlis Alla | See Remarks | Grant(A) | 40K | — | $0 |
| Jan 1, 2025 | Yablonka Uri | EVP & Chief Business Officer, Director | Grant(A) | 40K | — | $0 |
| Jan 1, 2025 | Yablonka Uri | EVP & Chief Business Officer, Director | Grant(A) | 20K | — | $0 |
| Jan 1, 2025 | Polverino Anthony J. | Director | Grant(A) | 24K | — | $0 |
| Jan 1, 2025 | Frenkel Jacob A | Director | Grant(A) | 40K | — | $0 |
| Jan 1, 2025 | Lebovits Chaim | President & CEO | Grant(A) | 120K | — | $0 |
| Jan 1, 2025 | Dagher Ibrahim B. | Chief Medical Officer | Grant(A) | 50K | — | $0 |
| Oct 1, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 2K | $3.43 | $6K |
| Sep 30, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 22K | $0.23 | $5K |
| Jul 19, 2024 | Dagher Ibrahim B. | Chief Medical Officer | Sell(S) | 63K | $0.35 | $22K |
| Jun 24, 2024 | Hartounian Hartoun | EVP, Chief Operating Officer | Grant(A) | 30K | — | $0 |
| Jun 24, 2024 | Hartounian Hartoun | EVP, Chief Operating Officer | Grant(A) | 60K | — | $0 |
| May 28, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 15K | $0.52 | $8K |
| May 22, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 25K | $0.64 | $16K |
| May 21, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 25K | $0.58 | $15K |
| May 13, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 10K | $0.49 | $5K |
| May 11, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 10K | $0.47 | $5K |
| May 10, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 20K | $0.47 | $9K |
| May 7, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 66K | $0.37 | $25K |
| May 6, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 135K | $0.38 | $51K |
| Apr 19, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 15K | $0.52 | $8K |
| Apr 18, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 115K | $0.53 | $61K |
| Apr 17, 2024 | Lebovits Chaim | President & CEO | Buy(P) | 130K | $0.55 | $72K |
| Mar 11, 2024 | Lebovits Chaim | President & CEO | Grant(A) | 305K | — | $0 |
| Mar 11, 2024 | Patlis Alla | See Remarks | Grant(A) | 65K | — | $0 |
| Mar 11, 2024 | Yablonka Uri | EVP & Chief Business Officer, Director | Grant(A) | 109K | — | $0 |
| Mar 11, 2024 | Lindborg Stacy | Co-Chief Executive Officer | Grant(A) | 242K | — | $0 |
| Sep 1, 2023 | Lindborg Stacy | Co-Chief Executive Officer | Buy(P) | 12K | $1.77 | $20K |
| Aug 2, 2023 | Lebovits Chaim | President & CEO | Grant(A) | 31K | — | $0 |
| Aug 2, 2023 | Lindborg Stacy | Co-Chief Executive Officer | Grant(A) | 35K | — | $0 |
| Jun 19, 2023 | Naor Nir | Director | Grant(A) | 12K | — | $0 |
| May 1, 2023 | Taylor Kirk | Chief Medical Officer | Grant(A) | 35K | — | $0 |
| May 1, 2023 | Taylor Kirk | Chief Medical Officer | Grant(A) | 80K | — | $0 |
| Apr 20, 2023 | Lindborg Stacy | Co-Chief Executive Officer | Grant(A) | 75K | — | $0 |
| Apr 20, 2023 | Lebovits Chaim | President & Co-CEO | Grant(A) | 75K | — | $0 |
| Dec 7, 2022 | Lindborg Stacy | Co-Chief Executive Officer | Grant(A) | 35K | — | $0 |
| Sep 18, 2022 | Lebovits Chaim | Chief Executive Officer | Grant(A) | 31K | — | $0 |
| Apr 6, 2022 | Frenkel Jacob A | Director | Grant(A) | 50K | — | $0 |
| Mar 6, 2022 | Kern Ralph Dr. | COO and Chief Medical Officer | Grant(A) | 36K | — | $0 |
| Feb 1, 2022 | Polverino Anthony J. | Director | Grant(A) | 4K | — | $0 |
| Dec 15, 2021 | Arbel Irit | Director | Grant(A) | 25K | — | $0 |
| Dec 15, 2021 | Yablonka Uri | Director | Grant(A) | 13K | — | $0 |
| Dec 15, 2021 | Almenoff June Sherie | Director | Grant(A) | 2K | — | $0 |
| Dec 15, 2021 | Polverino Anthony J. | Director | Grant(A) | 2K | — | $0 |
| Dec 15, 2021 | Taub Malcolm S | Director | Grant(A) | 12K | — | $0 |
| Dec 10, 2021 | Almenoff June Sherie | Director | Grant(A) | 2K | — | $0 |
| Dec 10, 2021 | Yablonka Uri | Director | Grant(A) | 13K | — | $0 |
| Dec 10, 2021 | Abbhi Sankesh | Director | Grant(A) | 7K | — | $0 |
| Dec 10, 2021 | Frenkel Jacob A | Director | Grant(A) | 50K | — | $0 |
| Dec 10, 2021 | Arbel Irit | Director | Grant(A) | 25K | — | $0 |
| Dec 10, 2021 | Polverino Anthony J. | Director | Grant(A) | 2K | — | $0 |
| Dec 10, 2021 | Polverino Anthony J. | Director | Grant(A) | 2K | — | $0 |
| Dec 10, 2021 | Taub Malcolm S | Director | Grant(A) | 12K | — | $0 |
| Dec 10, 2021 | Lebovits Chaim | Chief Executive Officer | Grant(A) | 31K | — | $0 |
| Dec 10, 2021 | Kern Ralph Dr. | COO and Chief Medical Officer | Grant(A) | 36K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).